Evaluating cement treatment for pelvic bone lesions in elderly patients
Percutaneous Cementoplasty With or Without Screw Fixation for Bony Pelvis Lesions in Elderly Patients : Feasibility, Safety and Clinical Outcomes.
This study looks at whether a minimally invasive cement treatment can help older patients with pelvic bone fractures or tumors feel better and recover safely.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 40 (estimated) |
| Ages | 80 Years and up |
| Sex | All |
| Sponsor | Centre Hospitalier Universitaire de Saint Etienne Academic / other |
| Locations | 1 site (Saint-Etienne) |
| Trial ID | NCT05868863 on ClinicalTrials.gov |
What this trial studies
This observational study aims to retrospectively assess the outcomes of percutaneous cementoplasty in patients aged 80 and over who have osteoporotic fractures or neoplastic lesions affecting the pelvis. The study will analyze data from medical records of patients treated at the university hospital center of Saint-Etienne between January 2012 and February 2023. The focus is on evaluating the feasibility, safety, and efficiency of this minimally invasive treatment approach, particularly for the elderly population who are often more fragile and at higher risk for such conditions.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals aged 80 and over who have undergone percutaneous cementoplasty for pelvic bone lesions.
Not a fit: Patients who have received other interventional treatments at the same time and location may not benefit from this study.
Why it matters
Potential benefit: If successful, this treatment could significantly reduce pain and improve functional outcomes for elderly patients with pelvic bone lesions.
How similar studies have performed: While this approach is increasingly utilized, the specific outcomes of cementoplasty in this age group have not been extensively studied, making this a novel evaluation.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with lesion of the bony pelvis treated by percutaneous cementoplasty with or without screw fixation at university hospital center of Saint-Etienne between January 1st 2012 and February 28th 2023 Exclusion Criteria: * Other interventional treatment at the same time and at the same location
Where this trial is running
Saint-Etienne
- CHU Saint-Etienne — Saint-Etienne, France (Recruiting)
Study contacts
- Principal investigator: Sylvain GRANGE, MD — Centre Hospitalier Universitaire de Saint Etienne
- Study coordinator: Sylvain GRANGE, MD
- Email: grangesylvain@hotmail.fr
- Phone: (0)477127827
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.